EMD Serono Advances Patient Access to IVF Medicines in the US with New Pathways and Trump Administration Collaboration.

EMD Serono, a healthcare business of Merck KGaA, has collaborated with the Trump Administration to expand access to its fertility medication portfolio in the US. Prescribed patients can now access a single coupon covering the company's complete fertility medication portfolio on TrumpRx.gov. The collaboration aims to make infertility treatments more accessible to the 10 million women in the US who struggle to have a baby.